Back to search
FDAFDA · Food and drugs·Recall number D-0303-2025

8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4

Published April 2, 2025 · Recall initiated: March 7, 2025

Summary

FDA records drug Class II recall D-0303-2025, published April 2, 2025 and initiated March 7, 2025. Recalling firm: Exela Pharma Sciences LLC; Status: Ongoing; Reported quantity: 103,950 vials; Lot: Lots: 10006417 and 10006418, Exp. 11/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email if SODIUM BICARBONATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SODIUM BICARBONATE
Manufacturer
Exela Pharma Sciences LLC
Distributor
Nationwide
Lot
Lots: 10006417 and 10006418, Exp. 11/30/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4 recalled?

Yes. FDA published recall D-0303-2025 on April 2, 2025. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SODIUM BICARBONATE.